Prospective diagnostic study of 40 asymptomatic patients with large-head metal-on-metal THA. Each patient underwent both ultrasound and SEMAC MRI to compare their accuracy for detecting pseudotumors. The question: which modality is the better first-line screen for adverse local tissue reactions?
When screening an asymptomatic patient with a large-head metal-on-metal THA, reach for ultrasound first, not MRI. Both tests performed equally well here, so the deciding factor is cost and access. Ultrasound is 100% sensitive, so a negative scan lets you confidently exclude a pseudotumor and avoid an expensive MRI.
Remember that pseudotumor prevalence was 31% even in patients with excellent WOMAC scores and no complaints. Being asymptomatic does not mean being disease-free, which is why regulatory agencies recommend cross-sectional imaging for these implants at all.
The main caveat: ultrasound is operator-dependent and struggles with deep tissue in obese patients, so its accuracy depends on an experienced sonographer. The true gold standard remains intraoperative pathology; the study used concordant ultrasound and MRI as a surrogate, which the authors acknowledge could miss lesions both tests get wrong.
Prospective diagnostic study of 40 asymptomatic patients with large-head metal-on-metal THA. Each patient underwent both ultrasound and SEMAC MRI to compare their accuracy for detecting pseudotumors. The question: which modality is the better first-line screen for adverse local tissue reactions?
When screening an asymptomatic patient with a large-head metal-on-metal THA, reach for ultrasound first, not MRI. Both tests performed equally well here, so the deciding factor is cost and access. Ultrasound is 100% sensitive, so a negative scan lets you confidently exclude a pseudotumor and avoid an expensive MRI.
Remember that pseudotumor prevalence was 31% even in patients with excellent WOMAC scores and no complaints. Being asymptomatic does not mean being disease-free, which is why regulatory agencies recommend cross-sectional imaging for these implants at all.
The main caveat: ultrasound is operator-dependent and struggles with deep tissue in obese patients, so its accuracy depends on an experienced sonographer. The true gold standard remains intraoperative pathology; the study used concordant ultrasound and MRI as a surrogate, which the authors acknowledge could miss lesions both tests get wrong.